Phibro Animal Health Past Earnings Performance
Past criteria checks 1/6
Phibro Animal Health's earnings have been declining at an average annual rate of -13.1%, while the Pharmaceuticals industry saw earnings growing at 1.7% annually. Revenues have been growing at an average rate of 4.6% per year. Phibro Animal Health's return on equity is 5.5%, and it has net margins of 1.5%.
Key information
-13.1%
Earnings growth rate
-13.1%
EPS growth rate
| Pharmaceuticals Industry Growth | 6.0% |
| Revenue growth rate | 4.6% |
| Return on equity | 5.5% |
| Net Margin | 1.5% |
| Next Earnings Update | 08 May 2024 |
Recent past performance updates
Recent updates
Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12
Feb 10
Phibro Animal Health (NASDAQ:PAHC) Use Of Debt Could Be Considered Risky
Dec 06Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12
Nov 10A Look At The Fair Value Of Phibro Animal Health Corporation (NASDAQ:PAHC)
Nov 05Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Aug 28Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12
Jul 29Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12
Feb 10Is Phibro Animal Health Corporation (NASDAQ:PAHC) Worth US$13.8 Based On Its Intrinsic Value?
Dec 23Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12
Aug 26Phibro Animal Non-GAAP EPS of $0.36 misses by $0.02, revenue of $255.3M beats by $5.26M
Aug 24Is Phibro Animal Health (NASDAQ:PAHC) A Risky Investment?
Aug 24Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Jul 29Phibro Animal declares $0.12 dividend
Jul 25Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be US$0.12
May 06Phibro Animal Health (NASDAQ:PAHC) Has Announced A Dividend Of US$0.12
Feb 11Phibro Animal Health (NASDAQ:PAHC) Has Re-Affirmed Its Dividend Of US$0.12
Nov 05We Discuss Why Phibro Animal Health Corporation's (NASDAQ:PAHC) CEO Compensation May Be Closely Reviewed
Oct 26Does Phibro Animal Health (NASDAQ:PAHC) Have A Healthy Balance Sheet?
Aug 26Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be US$0.12
Jul 30Revenue & Expenses BreakdownBeta
How Phibro Animal Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 982 | 15 | 238 | 0 |
| 30 Sep 23 | 977 | 21 | 230 | 0 |
| 30 Jun 23 | 978 | 33 | 216 | 0 |
| 31 Mar 23 | 978 | 29 | 225 | 0 |
| 31 Dec 22 | 972 | 36 | 215 | 0 |
| 30 Sep 22 | 960 | 46 | 209 | 0 |
| 30 Jun 22 | 942 | 49 | 204 | 0 |
| 31 Mar 22 | 907 | 59 | 201 | 0 |
| 31 Dec 21 | 879 | 53 | 199 | 0 |
| 30 Sep 21 | 853 | 49 | 198 | 0 |
| 30 Jun 21 | 833 | 54 | 194 | 0 |
| 31 Mar 21 | 799 | 43 | 191 | 0 |
| 31 Dec 20 | 798 | 44 | 190 | 0 |
| 30 Sep 20 | 806 | 43 | 191 | 0 |
| 30 Jun 20 | 800 | 34 | 190 | 0 |
| 31 Mar 20 | 818 | 37 | 192 | 0 |
| 31 Dec 19 | 813 | 38 | 185 | 0 |
| 30 Sep 19 | 818 | 41 | 180 | 0 |
| 30 Jun 19 | 828 | 55 | 176 | 0 |
| 31 Mar 19 | 836 | 68 | 168 | 0 |
| 31 Dec 18 | 839 | 73 | 172 | 0 |
| 30 Sep 18 | 827 | 65 | 170 | 0 |
| 30 Jun 18 | 820 | 65 | 167 | 0 |
| 31 Mar 18 | 803 | 58 | 167 | 0 |
| 31 Dec 17 | 784 | 62 | 161 | 0 |
| 30 Sep 17 | 770 | 68 | 158 | 0 |
| 30 Jun 17 | 764 | 65 | 153 | 0 |
| 31 Mar 17 | 759 | 64 | 153 | 0 |
| 31 Dec 16 | 752 | 59 | 152 | 0 |
| 30 Sep 16 | 752 | 76 | 152 | 0 |
| 30 Jun 16 | 752 | 83 | 151 | 0 |
| 31 Mar 16 | 747 | 78 | 153 | 0 |
| 31 Dec 15 | 751 | 76 | 152 | 0 |
| 30 Sep 15 | 748 | 60 | 148 | 0 |
| 30 Jun 15 | 749 | 60 | 145 | 0 |
| 31 Mar 15 | 747 | 32 | 140 | 0 |
| 31 Dec 14 | 733 | 22 | 138 | 0 |
| 30 Sep 14 | 717 | 10 | 136 | 0 |
| 30 Jun 14 | 692 | -3 | 135 | 0 |
| 31 Mar 14 | 672 | 20 | 122 | 7 |
| 31 Dec 13 | 662 | 18 | 119 | 7 |
| 30 Sep 13 | 652 | 23 | 114 | 7 |
| 30 Jun 13 | 653 | 25 | 118 | 0 |
Quality Earnings: PAHC has high quality earnings.
Growing Profit Margin: PAHC's current net profit margins (1.5%) are lower than last year (3.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PAHC's earnings have declined by 13.1% per year over the past 5 years.
Accelerating Growth: PAHC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: PAHC had negative earnings growth (-59.2%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-6.8%).
Return on Equity
High ROE: PAHC's Return on Equity (5.5%) is considered low.